Company intelligence / Profile preview

Unicity

Ownership: Private
Development stage: Commercial

Overview

Unicity has developed over 400 science-backed nutritional products focused on improving metabolic health. Some of its innovations include patented processes for increasing resolvin production from omega fatty acids and proprietary blends supporting gene expression. Products have been listed in the Prescribers’ Digital Reference and supported by clinical studies.

Therapeutic areas: ImmunologyMetabolic DisordersCardiovascularEndocrinology
Modalities: Nutritional supplementSmall molecule
Industry: Food & Nutrition

Drug pipeline

3 assets

Balance

Commercial

Indications: Metabolic health

2 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with ingredient suppliers and academic partners for research; specifics not disclosed.

Beyond the preview

Go deeper on Unicity.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Unicity.

Explore the full profile